In Silico Evaluation of Bioactive Compounds from Caesalpinia sappan L. as Lipase and Penicillin-Binding Protein Inhibitors for Antibacterial Therapy. Pharmaceutical Reports, v. 5, n. 1, 31 Mar.2026.